NeoGenomics on 'More Solid Footing' With Strong Revenue Growth, Needham Says
MT newswire2026/10/06 18:4202:42 PM EDT, 10/06/2026 (MT Newswires) -- NeoGenomics (NEO) is on "more solid footing" even after another change in the chief executive officer role, Needham said in a Tuesday note, citing revenue growth in next-generation sequencing and reimbursement wins for RaDaR MRD. Current Chief Operating Officer Warren Stone is set to become the company's fifth CEO in the past six years, as he succeeds current CEO Tony Zook on Jan. 4, Needham analysts said. Further, the analysts said they were "encouraged" by the company's above-consensus Q3 revenue guidance of about $209 million, including year-over-year next-generation sequencing revenue growth of around 28%. Needham reiterated the company's stock at buy and raised the price target to $22 from $19. Price: 16.70, Change: -2.43, Percent Change: -12.71
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.


Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
